Delivery Order SPE2DB22D1106-SPE2DB25FFFH9
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for 1,440 units of HAVRIX 1,440 Unit/mL syringes, valued at $3,227.60. This firm fixed-price delivery order, which is set to be completed by June 27, 2025, represents a pediatric hepatitis A vaccine supply to support federal medical procurement needs. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $11,463.02 delivery order to AmerisourceBergen Drug Corp for 1,440 units/mL of HAVRIX vaccine syringes on July 28, 2025, with completion targeted for July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,666.37 firm fixed price delivery order for 1,440 units of HAVRIX 1,440 Unit/mL syringe on April 18, 2025, with ultimate completion scheduled for April 21, 2025. This non-set-aside contract was competitively awarded to AmerisourceBergen's Corporate Office, with performance to occur at the company's Conshohocken, Pennsylvania headquarters. HAVRIX is a hepatitis A vaccine commonly utilized by the Department of Defense for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of 1,440 units of HAVRIX 1,440 Unit/mL syringes valued at $1,931.08. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of HAVRIX 1,440 unit/mL syringes, a hepatitis A vaccine product. This non-set-aside, competitively awarded contract is structured as a delivery order with firm fixed pricing and a ceiling value of $3,059.79. The contract is anticipated to reach ultimate completion on July 21, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $3,776.30 delivery order to AmerisourceBergen Drug Corp for Havrix 720 Unit/0.5 mL syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract represents a pediatric hepatitis A vaccine delivery through AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Havrix 720 Unit/0.5 ML syringes, a hepatitis A vaccine product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,012.20 and is scheduled for completion by August 8, 2025. The contract utilizes no set-aside designation and represents a direct procurement of pharmaceutical products to support federal healthcare requirements. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine product, reflecting the ongoing federal medical procurement needs for...
- The Defense Logistics Agency awarded a $4,048.80 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of HAVRIX 720 Unit/0.5 ML syringes. This firm fixed-price contract, with an ultimate completion date of August 22, 2025, represents a pediatric hepatitis A vaccine delivery to support federal medical procurement needs. The award was made through open competition with no set-aside designation, with performance to take place at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $1,853.12 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of HAVRIX 720 Unit/0.5 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a pediatric hepatitis A vaccine product critical for military healthcare and immunization programs. This...